BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11323427)

  • 1. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
    Miyake JH; Doung XD; Strauss W; Moore GL; Castellani LW; Curtiss LK; Taylor JM; Davis RA
    J Biol Chem; 2001 Jun; 276(26):23304-11. PubMed ID: 11323427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1.
    Wang SL; Du EZ; Martin TD; Davis RA
    J Biol Chem; 1997 Aug; 272(31):19351-8. PubMed ID: 9235933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2000 George Lyman Duff Memorial Lecture: atherosclerosis is a liver disease of the heart.
    Davis RA; Hui TY
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):887-98. PubMed ID: 11397693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM; Groenendijk M; Solaas K; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indinavir alters sterol and fatty acid homeostatic mechanisms in primary rat hepatocytes by increasing levels of activated sterol regulatory element-binding proteins and decreasing cholesterol 7alpha-hydroxylase mRNA levels.
    Williams K; Rao YP; Natarajan R; Pandak WM; Hylemon PB
    Biochem Pharmacol; 2004 Jan; 67(2):255-67. PubMed ID: 14698038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
    Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
    Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of okra is mediated through inhibition of lipogenesis and upregulation of cholesterol degradation.
    Wang H; Chen G; Ren D; Yang ST
    Phytother Res; 2014 Feb; 28(2):268-73. PubMed ID: 23606408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia.
    Ratliff EP; Gutierrez A; Davis RA
    J Lipid Res; 2006 Jul; 47(7):1513-20. PubMed ID: 16609145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.
    Li T; Francl JM; Boehme S; Chiang JY
    Hepatology; 2013 Sep; 58(3):1111-21. PubMed ID: 23536474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL.
    Horton JD; Shimano H; Hamilton RL; Brown MS; Goldstein JL
    J Clin Invest; 1999 Apr; 103(7):1067-76. PubMed ID: 10194480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol and hepatic lipoprotein assembly and secretion.
    Kang S; Davis RA
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):223-30. PubMed ID: 11111091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
    Post SM; Groenendijk M; van der Hoogt CC; Fievet C; Luc G; Hoekstra M; Princen HM; Staels B; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2724-30. PubMed ID: 17008588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
    Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
    J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding.
    Repa JJ; Lund EG; Horton JD; Leitersdorf E; Russell DW; Dietschy JM; Turley SD
    J Biol Chem; 2000 Dec; 275(50):39685-92. PubMed ID: 11001949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
    Basciano H; Miller A; Baker C; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
    Shimano H; Horton JD; Hammer RE; Shimomura I; Brown MS; Goldstein JL
    J Clin Invest; 1996 Oct; 98(7):1575-84. PubMed ID: 8833906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
    Huff MW; Telford DE; Edwards JY; Burnett JR; Barrett PH; Rapp SR; Napawan N; Keller BT
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1884-91. PubMed ID: 12426220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
    J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.